Anti-rejection medications for transplant recipients protect against Alzheimer's disease

(University of Texas Medical Branch at Galveston) A new study from the University of Texas Medical Branch at Galveston has revealed that a treatment taken daily by people who have had organ transplants to prevent organ rejection protects against Alzheimer's disease. An early online version of this paper detailing the findings has been published and is scheduled for publication in the July 7 issue of the Journal of Alzheimer's Disease.